CMS 347 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

Overview

CMS347v3 (2020)

CMS347v4 (2021)

CMS347v5 (2022)

Identifiers

CMS eCQM ID NQF eCQM ID NQF MIPS Quality ID
CMS347v5 โ€“ โ€“ 438

*MIE only supports data collection and reporting using eCQM specifications

Definitions

Description Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period
All patients who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD), including an ASCVD procedure Patients aged >= 20 years who have ever had a low-density lipoprotein cholesterol (LDL-C) level >= 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia Patients aged 40-75 years with a diagnosis of diabetes
Initial Patient Population All patients who were previously diagnosed with or currently have an active diagnosis of clinical ASCVD, including an ASCVD procedure Patients aged >= 20 years at the beginning of the measurement period who have ever had a laboratory result of LDL-C >=190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia Patients aged 40 to 75 years at the beginning of the measurement period with Type 1 or Type 2 diabetes
Denominator Equals Initial Population
Denominator Exclusions
  • Patients who have a diagnosis of pregnancy at any time during the measurement period
  • Patients who are breastfeeding at any time during the measurement period
  • Patients who have a diagnosis of rhabdomyolysis at any time during the measurement period
Numerator Patients who are actively using or who receive an order (prescription) for statin therapy at any time during the measurement period
Numerator Exclusions โ€“
Denominator Exceptions
  • Patients with statin-associated muscle symptoms or an allergy to statin medication
  • Patients who are receiving palliative or hospice care
  • Patients with active liver disease or hepatic disease or insufficiency
  • Patients with end-stage renal disease (ESRD)

Additional Information

Measure Type Process measure
Measure Scoring Proportion measure
Rate Aggregation Performance Rate = (Numerator 1 + Numerator 2 +Numerator 3)/ [(Denominator 1 - Denominator Exclusions 1- Denominator Exceptions 1) + (Denominator 2 - Denominator Exclusions 2 - Denominator Exceptions 2) +(Denominator 3 - Denominator Exclusions 3 - Denominator Exceptions 3)]
Granularity Patient
Improvement Notation Higher score indicates better quality
Domain Effective Clinical Care

Clinical Instructions

New UI Visit Encounter (valid RC202109+)

Original Visit Encounter

Evidence

Initial Patient Population

Name Value Set
Diagnosis: Atherosclerosis and Peripheral Arterial Disease 2.16.840.1.113762.1.4.1047.21
Diagnosis: Cerebrovascular Disease, Stroke, TIA 2.16.840.1.113762.1.4.1047.44
Diagnosis: Diabetes 2.16.840.1.113883.3.464.1003.103.12.1001
Diagnosis: Familial Hypercholesterolemia 2.16.840.1.113762.1.4.1047.100
Diagnosis: Ischemic Heart Disease or Other Related Diagnoses 2.16.840.1.113762.1.4.1047.46
Diagnosis: Myocardial Infarction 2.16.840.1.113883.3.526.3.403
Diagnosis: Stable and Unstable Angina 2.16.840.1.113762.1.4.1047.47
Encounter, Performed: Annual Wellness Visit 2.16.840.1.113883.3.526.3.1240
Encounter, Performed: Office Visit 2.16.840.1.113883.3.464.1003.101.12.1001
Encounter, Performed: Outpatient Consultation 2.16.840.1.113883.3.464.1003.101.12.1008
Encounter, Performed: Outpatient Encounters for Preventive Care 2.16.840.1.113883.3.526.3.1576
Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1025
Encounter, Performed: Preventive Care Services - Other 2.16.840.1.113883.3.464.1003.101.12.1030
Encounter, Performed: Preventive Care Services-Individual Counseling 2.16.840.1.113883.3.464.1003.101.12.1026
Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1023

Denominator Exclusions

Name Value Set
Diagnosis: Breastfeeding 2.16.840.1.113762.1.4.1047.73
Diagnosis: Pregnancy or Other Related Diagnoses 2.16.840.1.113883.3.600.1.1623
Diagnosis: Rhabdomyolysis 2.16.840.1.113762.1.4.1047.102

Numerator

Name Value Set

Denominator Exceptions

Name Value Set
Adverse Event: Statin Allergen 2.16.840.1.113762.1.4.1110.42
Allergy/Intolerance: Statin Allergen 2.16.840.1.113762.1.4.1110.42
Diagnosis: End Stage Renal Disease 2.16.840.1.113883.3.526.3.353
Diagnosis: Hepatitis A 2.16.840.1.113883.3.464.1003.110.12.1024
Diagnosis: Hepatitis B 2.16.840.1.113883.3.67.1.101.1.269
Diagnosis: Liver Disease 2.16.840.1.113762.1.4.1047.42
Diagnosis: Statin Associated Muscle Symptoms 2.16.840.1.113762.1.4.1108.85
Encounter, Performed: Encounter for palliative care ICD10CM Code Z51.5
Intervention, Order: Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584
Intervention, Order: Palliative or Hospice Care 2.16.840.1.113883.3.600.1.1579
Intervention, Performed: Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584

Source(s)

eCQI CMS347


Enterprise Health and WebChart Preview Documentation

Last Updated:

Last Build: Fri, 13 Dec 2024 17:11:57 UTC
WikiGDrive Version: 2aacb51f060d0354a678419290943a99bd16aad1